Skip to main content

Angel Michael Ortiz Zuñiga

Institutions of which they are part

Postdoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Angel Michael Ortiz Zuñiga

Institutions of which they are part

Postdoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Individualización de la Monitorización continua de glucosa en la población anciana con diabetes mellitus tipo 2 en función del Estado cognitivo

IP: Monica Sanchez Bartres
Collaborators: Angel Michael Ortiz Zúñiga, Ana Maria Ortiz de Urbina Olive, Judit Amigó Farran, Mercè Abad Martín, Olga Simó Servat, Pedro Alejandro Gil Millán
Funding agency: Sociedad Española de Diabetes
Funding: 20000
Reference: SED/SANCHEZ/2023
Duration: 01/12/2023 - 31/05/2025

(INFLAMWAT) - Mecanismos involucrados en la resolución de la inflamación del tejido adiposo en respuesta a restricción calórica

IP: Josep A Villena Delgado
Collaborators: Angel Michael Ortiz Zúñiga, Laura Hidalgo Corbacho, Alba Rojano Toimil, Ramón Vilallonga Puy
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 217800
Reference: PID2021-123377OB-I00
Duration: 01/09/2022 - 31/08/2025

Ministerio de Ciencia

Diabetis i metabolisme

IP: Rafael Simó Canonge
Collaborators: Josep A Villena Delgado, Carles Zafon Llopis, Cristina Hernández Pascual, David Martinez Selva, Rosario Pardo Diaz, Angel Michael Ortiz Zúñiga, Andreea Ciudin Mihai, Fiorella Ximena Palmas Candia, Ana Maria Ortiz de Urbina Olive, Monica Sanchez Bartres, Lorena Ramos Pérez, Marc Rivas Agudo, Diabetis i metabolisme, Anna Casteras Román, Alejandra Planas Vilaseca, Betina Biagetti Biagetti, Judit Amigó Farran, Mercè Abad Martín, Marta Comas Martínez, Hugo Ramos Abellan, Rosa Burgos Peláez, David Sabater Martínez, Olga Simó Servat, Patricia Bogdanov Baruj, Maria Llorian Salvador, Enzamaría Fidilio Meli
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00655
Duration: 01/01/2022 - 30/06/2025

Non-invasive assessment of advanced glycation end-products (AGEs) and diabetic outcomes: an integrated pilot study

IP: Cristina Hernández Pascual
Collaborators: Angel Michael Ortiz Zúñiga, Andreea Ciudin Mihai, Olga Simó Servat
Funding agency: European Foundation for the Study of Diabetes
Funding: 98000
Reference: AGE_EFSDSANOFI2017
Duration: 01/09/2017 - 31/08/2018

Related news

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Related professionals

Paula Duch Vega

Paula Duch Vega

Predoctoral researcher
Neurotraumatology and Neurosurgery Research Unit (UNINN)
Read more
Maria Victoria Sala Sanz de Madrid

Maria Victoria Sala Sanz de Madrid

Administration and Management
Stroke research
Read more
Arnau Hervera Abad

Arnau Hervera Abad

Main researcher
Clinical Neuroimmunology
Read more
Cristina de Dios Conde

Cristina de Dios Conde

Tècnic/a Superior Recerca
High Technology Unit (UAT)
Preclinical Core Facilities
External Strategy Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.